3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Renal Cell
22
Carcinoma, Hepatocellular
7
Kidney Neoplasms
6
Osteosarcoma
5
Sarcoma, Ewing
4
Neoplasm Metastasis
4
Sarcoma
3
Clear-cell metastatic renal cell carcinoma
3
Recurrence
2
Prostatic Neoplasms
2
Neuroendocrine Tumors
2
Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Carcinoma, Non-Small-Cell Lung
2
Carcinoma
2
Adrenocortical Carcinoma
2
von Hippel-Lindau Disease
1
Wilms Tumor
1
Urogenital Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Urachal adenocarcinoma
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Sjogren's Syndrome
1
Scleroderma, Systemic
1
Rhabdomyosarcoma
1
Rhabdoid Tumor
1
Refractory Differentiated Thyroid Gland Carcinoma
1
Interventions
darolutamide
3
Pluvicto
3
Docetaxel
3
testosterone 17 beta-cypionate
2
sipuleucel-T
1
lactitol
1
fludarabine phosphate
1
fludarabine
1
enzalutamide
1
ebastine
1
cabozantinib
1
cabazitaxel
1
Standard of Care
1
Prednisone
1
Prednisolone
1
PSMA-617
1
Gonadotropin-Releasing Hormone
1
Cyclophosphamide
1
Bortezomib
1
Blood Specimen Collection
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Metastatic Castration-resistant Prostate Cancer
×
cabozantinib
×
Clear all
NCT05613894
2025-10-31
CaboLu
University of Utah
Phase 1
Recruiting
33 enrolled